{"issuance_frequency":"","notes_translated":{"fr":"La présente norme d'étiquetage contient les exigences nécessaires à la présentation d'une autorisation de mise en marché (numéro d'identification du médicament [DIN]) pour des décongestionnants nasaux topiques en ventre libre destinés aux adultes et les enfants 12 ans ou plus qui contiennent du chlorhydrate d'oxymétazoline ou de la xylométazoline d'oxymétazoline comme ingrédient unique et qui visent à soulager la congestion nasale.","en":"This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion."},"issn":"","imso_approval":"true","isbn":"","creator":"","org_section":{"fr":"","en":""},"jurisdiction":"federal","private":false,"maintainer_email":"open-ouvert@tbs-sct.gc.ca","num_tags":0,"edition":"","frequency":"as_needed","data_series_issue_identification":{"fr":"","en":""},"contributor":{"fr":"","en":""},"maintainer":null,"ready_to_publish":"true","id":"14003711-c2ea-4e0f-9448-034c16a50790","metadata_created":"2021-09-09T12:31:56.062648","subject":["health_and_safety"],"pspc_identification_number":"","metadata_modified":"2021-09-09T12:31:56.062654","author":null,"author_email":null,"geographic_region":[],"portal_release_date":"2021-09-09","digital_object_identifier":"","state":"active","version":null,"keywords":{"fr":["Décongestionnants nasaux topiques en vente libre","norme d'étiquetage","autorisation de mise sur le marché","chlorhydrate d'oxymétazoline","chlorhydrate de xylométazoline"],"en":["Non-prescription topical nasal decongestants","labelling standard","market authorisation","oxymetazoline hydrochloride","xylometazoline hydrochloride"]},"relationships_as_object":[],"creator_user_id":"2dc5a12f-2a6f-4822-8514-165ea6bb05d9","title_translated":{"fr":"Ligne directrice - Norme d'étiquetage des médicaments décongestionnants nasaux topiques vendus sans ordonnance","en":"Guidance document - Nonprescription topical nasal decongestants labelling standard"},"type":"info","resources":[{"cache_last_updated":null,"unique_identifier":"","package_id":"14003711-c2ea-4e0f-9448-034c16a50790","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"8f196e66-fe65-422c-b879-b7ab98a434ea","related_relationship":"","name_translated":{"fr":"Ligne directrice - Norme d'étiquetage des médicaments décongestionnants nasaux topiques vendus sans ordonnance","en":"Guidance document - Nonprescription topical nasal decongestants labelling standard"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance document - Nonprescription topical nasal decongestants labelling standard","language":["en"],"created":"2021-09-09T12:31:56.139142","url":"https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/applications-submissions/guidance-documents/nonprescription-drugs-labelling-standards/nonprescription-topical-nasal-decongestants-labelling-standard.html","last_modified":null,"position":0,"revision_id":"9727f40f-1422-4e7f-a79a-8668bcb7dbd1","resource_type":"publication"},{"cache_last_updated":null,"unique_identifier":"","package_id":"14003711-c2ea-4e0f-9448-034c16a50790","datastore_contains_all_records_of_source_file":false,"datastore_active":false,"character_set":"","related_type":"","state":"active","id":"ab77afe0-61de-47e6-80c0-5ed1444287f4","related_relationship":"","name_translated":{"fr":"Ligne directrice - Norme d'étiquetage des médicaments décongestionnants nasaux topiques vendus sans ordonnance","en":"Guidance document - Nonprescription topical nasal decongestants labelling standard"},"hash":"","description":"","format":"HTML","date_published":"","mimetype_inner":null,"url_type":null,"mimetype":null,"cache_url":null,"name":"Guidance document - Nonprescription topical nasal decongestants labelling standard","language":["fr"],"created":"2021-09-09T12:31:56.139147","url":"https://www.canada.ca/fr/sante-canada/services/medicaments-produits-sante/medicaments/demandes-presentations/lignes-directrices/medicaments-vente-libre-normes-etiquetages-produits-pharmaceutiques/norme-etiquetage-medicaments-decongestionnants-nasaux-topiques-vendus-sans-ordonnance.html","last_modified":null,"position":1,"revision_id":"9727f40f-1422-4e7f-a79a-8668bcb7dbd1","resource_type":"publication"}],"place_of_publication":[],"num_resources":2,"tags":[],"spatial":"","collection":"publication","org_title_at_publication":{"fr":"Santé Canada","en":"Health Canada"},"date_published":"2017-05-18 00:00:00","issuance":"","groups":[],"license_id":"ca-ogl-lgo","data_series_name":{"fr":"","en":""},"relationships_as_subject":[],"license_title":"Open Government Licence - Canada","restrictions":"unrestricted","organization":{"description":"","created":"2016-09-23T17:25:33.001625","title":"Health Canada | Santé Canada","name":"hc-sc","is_organization":true,"state":"active","image_url":"","revision_id":"6a0471e8-36e5-4217-8f72-563c83e6465a","type":"organization","id":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","approval_status":"approved"},"name":"14003711-c2ea-4e0f-9448-034c16a50790","isopen":false,"additional_notes":{"fr":"","en":""},"departmental_identification_number":"","notes":"This labelling standard describes the requirements necessary to receive market authorisation ( Drug identification number (DIN)) for nonprescription topical nasal decongestant products containing oxymetazoline hydrochloride or xylometazoline hydrochloride as a single ingredient for use in adults and children 12 years of age and older to relieve nasal congestion.","owner_org":"BD26DB5E-82D2-42C1-99BB-08FCF6068FEE","program_page_url":{"fr":"","en":""},"url":null,"audience":[],"gc_catalogue_number":"","license_url":"http://open.canada.ca/en/open-government-licence-canada","series_publication_dates":{"fr":"","en":""},"title":"Guidance document - Nonprescription topical nasal decongestants labelling standard","revision_id":"9727f40f-1422-4e7f-a79a-8668bcb7dbd1"}